{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:21:07Z","timestamp":1762161667579},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Oncol. & Tumor Pharmacother."],"published-print":{"date-parts":[[1990,12]]},"DOI":"10.1007\/bf02987108","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T18:21:13Z","timestamp":1631902873000},"source":"Crossref","is-referenced-by-count":18,"title":["Suramin: The discovery of an old anticancer drug"],"prefix":"10.1007","volume":"7","author":[{"given":"A.","family":"ZAniboni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02987108_CR1","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.258.10.1347","volume":"258","author":"B D Cheson","year":"1987","unstructured":"Cheson B D, Levine A M, Mildvan D, Kaplan L D, Wolfe P, Rios A, Groopman J E, Gill P, Volberding P A, Poiesz B J: Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group.JAMA\n                           258, 1347 (1987).","journal-title":"JAMA"},{"key":"BF02987108_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0002-9343(87)90108-2","volume":"82","author":"L D Kaplan","year":"1987","unstructured":"Kaplan L D, Wolfe P R, Volderding P A, Feorino P, Levy J A, Abrams D I, Kiprov D, Wong R, Kaufman L, Gottlieb M S: Lack of response to Suramin in patients with AIDS and AIDS-related complex.Am J Med\n                           82, 615 (1987).","journal-title":"Am J Med"},{"key":"BF02987108_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1210\/jcem-65-1-153","volume":"65","author":"P. Raffled M Feuillan","year":"1987","unstructured":"Feuillan P. Raffled M, Stein C A, Lipford N, Rehnquist D, Meyers C A, LaRocca R V, Chrousos G P: Effect of suramin on the function and structure of the adrenal cortex in the cynomolgus monkey.J clin Endocrinol Meiab\n                           65, 153 (1987).","journal-title":"J clin Endocrinol Meiab"},{"key":"BF02987108_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/j.1552-4604.1986.tb02897.x","volume":"26","author":"J M Collins","year":"1986","unstructured":"Collins J M, Klecker R W, Yarchoan R, Lane H C, Fauci A S, Redfield R R, Broder S, Myers C E: Clinical pharmacokinetics of Suramin in patients with HTLV-III\/LAV infection.J clin Pharmacol\n                           26, 22 (1986).","journal-title":"J clin Pharmacol"},{"key":"BF02987108_CR5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0378-4347(00)84591-0","volume":"343","author":"G Edwards","year":"1935","unstructured":"Edwards G, Rodick C, Ward S A, Awadzi K, Orme M L, Breckenridge A M: Determination of Suramin in plasma by high-performance liquid chromato- graphy.J Chrom\n                           343, 224 (1935).","journal-title":"J Chrom"},{"key":"BF02987108_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0378-4347(00)80750-1","volume":"378","author":"R M Ruprecht","year":"1986","unstructured":"Ruprecht R M, Lorsch J, Trites D H: Analysis of suramin plasma levels by ion-pair high-performance liquid chromatography under isocratic conditions.J Chrom\n                           378, 498 (1986).","journal-title":"J Chrom"},{"key":"BF02987108_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1200\/JCO.1989.7.4.499","volume":"7","author":"C A Stein","year":"1989","unstructured":"Stein C A, LaRocca R V, Thomas R, McAtee N, Myers C E: Suramin: an anticancer drug with a unique mechanism of action.J clin Oncol\n                           7, 499 (1989).","journal-title":"J clin Oncol"},{"key":"BF02987108_CR8","first-page":"277","volume":"8","author":"R LaRocca","year":"1989","unstructured":"LaRocca R, Stein C, Myers C, Dalakis M, McAtee N: Suramin induced acute polyneuropathy.Proc ASCO\n                           8, 277 (1989).","journal-title":"Proc ASCO"},{"key":"BF02987108_CR9","first-page":"273","volume":"71","author":"M K Horne","year":"1988","unstructured":"Horne M K, Stein C A, LaRocca R V, Myers C E: Circulating glycosaminoglycan anticoagulants associated with Suramin treatment.Blood\n                           71, 273 (1988).","journal-title":"Blood"},{"key":"BF02987108_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jcp.1041320120","volume":"132","author":"R J Coffey","year":"1987","unstructured":"Coffey R J, Leof E B, Shipley G D, Moses H L: Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.J Cell Physiol\n                           132, 143 (1987).","journal-title":"J Cell Physiol"},{"key":"BF02987108_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jcb.240290310","volume":"29","author":"M Hosang","year":"1985","unstructured":"Hosang M: Suramin binds to platelet-derived growth factor and inhibits its biological activity.J Cell Biochem\n                           29, 265 (1985).","journal-title":"J Cell Biochem"},{"key":"BF02987108_CR12","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1073\/pnas.81.23.7466","volume":"81","author":"J Garret","year":"1984","unstructured":"Garret J, Coughlin S, Niman H: Blockade of automne Stimulation in simian sarcoma virus transformed cells reverses down-regulation of platelet-derived growth factor receptors.Proc Nad Acad Sci USA\n                           81, 7466 (1984).","journal-title":"Proc Nad Acad Sci USA"},{"key":"BF02987108_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1126\/science.2432664","volume":"235","author":"J Folkman","year":"1987","unstructured":"Folkman J, Klagsbrun M: Angiogenic factors.Science\n                           235, 442 (1987).","journal-title":"Science"},{"key":"BF02987108_CR14","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1002\/hep.1840070702","volume":"7","author":"M Fujita","year":"1987","unstructured":"Fujita M, Spray D, Choi H: Glycosaminoglycans and proteoglycans induce gap junction expression and restore transcription of tissue-specific mRNAs in primary liver cultures.Hepatology\n                           7, 1S-9S (1987).","journal-title":"Hepatology"},{"key":"BF02987108_CR15","unstructured":"In:The Clinical Cancer Letter\n                           11, 1 (1988)."},{"key":"BF02987108_CR16","first-page":"4694","volume":"47","author":"Z Spigelman","year":"1987","unstructured":"Spigelman Z, Dowers A, Kennedy S, DiSorbo D, O\u2019Brian M, Barr R, McCaffrey R: Antiproliferative effects of Suramin on lymphoid cells.Cancer Res\n                           47, 4694 (1987).","journal-title":"Cancer Res"},{"key":"BF02987108_CR17","first-page":"2170","volume":"30","author":"C Freter","year":"1989","unstructured":"Freter C: Synergistic growth inhibition of lymphoid tumor cells by Dexamethasone and Suramin.Proc AACR\n                           30, 2170 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR18","first-page":"304","volume":"30","author":"J Bergh","year":"1989","unstructured":"Bergh J: Suramin is a potent inhibitor of the cell proliferation in human non-small cell lung cancer cell lines.Proc AACR\n                           30, 304 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR19","first-page":"276","volume":"30","author":"T P Wade","year":"1989","unstructured":"Wade T P, Kasid A, Stein C A, LaRocca R V, Sargent E R, Gomella L G, Myers C E, Linehan W M: Suramin interferes with TGF-\u03b2 induced inhibition of human renal cell carcinoma.Proc AACR\n                           30, 276 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR20","first-page":"1172","volume":"30","author":"C Knabbe","year":"1989","unstructured":"Knabbe C, Kellner U, Schmahl M, Voigt K D: Suramin inhibits growth of human prostate carcinoma cells by inactivation of growth factor action.Proc AACR\n                           30, 1172 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR21","first-page":"1234","volume":"30","author":"H W Ewing","year":"1989","unstructured":"Ewing H W, LaRocca R V, Stein C A, Myers C E, Linehan W M: Effect of Suramin on proliferation of human prostate carcinoma.Proc AACR\n                           30, 1234 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR22","first-page":"2300","volume":"30","author":"R Danesi","year":"1989","unstructured":"Danesi R, LaRocca R, Stein C, Neckers L, Myers C: Effect of Suramin on the human glioma cell line U706T.Proc AACR\n                           30, 2300 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR23","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ijc.2910420618","volume":"42","author":"J M Culouscou","year":"1988","unstructured":"Culouscou J M, Garrouste F, Remache-Bonnet M, Bettetini D, Marvaldi J, Pommier G: Autocrine secretion of a colorectum-derived growth factor by HT-29 human colon carcinoma cell line.Int J Cancer\n                           42, 895 (1988).","journal-title":"Int J Cancer"},{"key":"BF02987108_CR24","first-page":"2218","volume":"30","author":"J Clark","year":"1989","unstructured":"Clark J, Chu M, Calabresi P: Growth inhibition of colon cancer cells by Genistein and Suramin,Proc AACR\n                           30, 2218 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR25","first-page":"A268","volume":"96","author":"R Kopp","year":"1989","unstructured":"Kopp R, Pfeiffer A: Antiproliferative effects of Suramin may be mediated by inhibition of growth factor receptor binding and reduction of phospho-inositide resynthesis in human colon carcinoma cells.Gastroenterology\n                           96, A268 (1989).","journal-title":"Gastroenterology"},{"key":"BF02987108_CR26","first-page":"229","volume":"30","author":"P S Dixon","year":"1989","unstructured":"Dixon P S, Ramirez A, Egan J W, Aust J B, Mover M P: Effects of transforming growth factor-\u03b2 on the in vitro growth of normal and malignant human gastrointestinal epithelial cells.Proc AACR\n                           30, 229 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR27","first-page":"H","volume":"30","author":"E Tahara","year":"1989","unstructured":"Tahara E, Yoshida K: Coexpression of EGF and EGF receptor in human gastric carcinoma.Proc AACR\n                           30, H-84 (1989).","journal-title":"Proc AACR"},{"key":"BF02987108_CR28","first-page":"2898","volume":"49","author":"M A Anzano","year":"1989","unstructured":"Anzano M A, Rieman D, Prichett W: Growth factor production by human colon carcinoma cell lines.Cancer Res\n                           49, 2898 (1989).","journal-title":"Cancer Res"},{"key":"BF02987108_CR29","doi-asserted-by":"crossref","unstructured":"Vierhapper H, Nowotny P, Mostbeck G, Waldhause W: Effect of Suramin in a patient with adrenocortical carcinoma.Lancet, 1208 (1989).","DOI":"10.1016\/S0140-6736(89)92790-6"},{"key":"BF02987108_CR30","first-page":"256","volume":"8","author":"C E Myers","year":"1989","unstructured":"Myers C E, Stein C, LaRocca R, Cooper M, Cassidy J, McAtee N: Suramin: an antagonist of heparin-binding tumor growth factors with activity against a broad spectrum of human tumors.Proc ASCO\n                           8, 256 (1989).","journal-title":"Proc ASCO"},{"key":"BF02987108_CR31","doi-asserted-by":"crossref","unstructured":"In:The Clinical Cancer Letter\n                           12, 5 (1989).","DOI":"10.1080\/07266472.1989.11083339"},{"key":"BF02987108_CR32","first-page":"2320","volume":"30","author":"A Wellstein","year":"1989","unstructured":"Wellstein A, Zugmaier G, Califano J, Broder S, Lippman M E: Xylanpolyhydrogensulfate inhibits fibroblast growth factor dependent growth of human tumor cells.Proc AACR\n                           30, 2320 (1989).","journal-title":"Proc AACR"}],"container-title":["Medical Oncology and Tumor Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02987108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02987108\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02987108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T19:26:20Z","timestamp":1631906780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02987108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["BF02987108"],"URL":"https:\/\/doi.org\/10.1007\/bf02987108","relation":{},"ISSN":["0736-0118"],"issn-type":[{"value":"0736-0118","type":"print"}],"subject":[],"published":{"date-parts":[[1990,12]]},"article-number":"287"}}